对于心肌梗死并发室性心律失常,《内科学》将利多卡因作为首选,但在“国际心肺复苏和心血管急救指南2000”中推荐了胺碘酮抗室性心律失常的治疗,但没有引起足够的重视,胺碘酮静脉注射用于心肌梗死中抗室速/室颤的治疗经验不多,但自2000年后胺碘酮静脉应用日益增多,在指南中[1] For myocardial infarction complicated by ventricular arrhythmias, Lectra was the first choice of the “internal medicine”, but amiodarone-induced arrhythmia was recommended in the International Cardiopulmonary Resuscitation and Cardiovascular Emergency Guidelines 2000 but did not cause Sufficient attention, intravenous amiodarone for myocardial infarction in the anti-ventricular tachycardia / ventricular fibrillation treatment experience, but since 2000, intravenous amiodarone is increasing, in the guidelines [1]